ArticleFrontiers in oncology2023

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.

Xin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.